According to the Cancer Genome Atlas/TCGA (https://cancergenome.nih.gov/), RAD9A is overexpressed in a wide variety of tumors including leukemia and solid tumors, supporting its oncogenic function but the relationship between tumor type, survival and RAD9A hypermethylation demands studying larger patients cohorts. Here, RAD9A is linked to leukemia.